Journal
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Volume 50, Issue 1, Pages 56-59Publisher
WILEY
DOI: 10.1111/j.1440-0960.2008.00506.x
Keywords
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate
Categories
Ask authors/readers for more resources
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available